[1]
Satyabrata Chaudhuri et al. 2022. A REVIEW OF ENDOCRINE-DISRUPTING COMPOUNDS AND BREAST CANCER DEVELOPMENT. Journal of Population Therapeutics and Clinical Pharmacology. 29, 04 (Apr. 2022), 5155–5173. DOI:https://doi.org/10.53555/11pd0s63.